Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Cosimi

Showing results (281-290 of 286) with videos related to

Pageof 29
Sort By:
You have reached the last page of results.This site can display upto 286 results.
Annals of Surgery|January 1, 1982
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesionsC L Day, M C Mihm, A J Sober, et al.
Journal of the American Academy of Dermatology|June 1, 1983
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosisC L Day, M C Mihm, A J Sober, et al.
Annals of Surgery|January 1, 1982
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasisC L Day, M C Mihm, R A Lew, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
Annals of Surgery|January 1, 1982
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox modelsC L Day, R A Lew, M C Mihm, et al.
Transplantation|July 27, 1997
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study GroupL S Sher, C A Cosenza, J Michel, et al.
Pageof 29

Showing results (281-290 of 286) with videos related to

Sort By:
Pageof 29
You have reached the last page of results.This site can display upto 286 results.
Annals of Surgery|January 1, 1982
Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesionsC L Day, M C Mihm, A J Sober, et al.
Journal of the American Academy of Dermatology|June 1, 1983
Predictors of late deaths among patients with clinical stage I melanoma who have not had bony or visceral metastases within the first 5 years after diagnosisC L Day, M C Mihm, A J Sober, et al.
Annals of Surgery|January 1, 1982
Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasisC L Day, M C Mihm, R A Lew, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanomaR Soiffer, T Lynch, M Mihm, et al.
Annals of Surgery|January 1, 1982
A multivariate analysis of prognostic factors for melanoma patients with lesions greater than or equal to 3.65 mm in thickness. The importance of revealing alternative Cox modelsC L Day, R A Lew, M C Mihm, et al.
Transplantation|July 27, 1997
Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study GroupL S Sher, C A Cosenza, J Michel, et al.
Pageof 29